Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Kern · SciRah

Researcher profile · Semantic Scholar

K. Kern

Share profile

K. Kern — researcher profile on SciRah

h-index: 27
Works: 90
Citations: 3,236

Most-cited papers

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J. Bergh, I. Bondarenko, M. Lichinitser, A. Liljegren +11 more
2012Journal of Clinical Oncology254 citations Open access
Semantic Scholar
Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
K. Kern
1999Journal of the American College of Surgeons219 citations
Semantic Scholar
A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
W. Messersmith, G. Shapiro, J. Cleary, A. Jimeno +10 more
2014Clinical Cancer Research207 citations Open access
Semantic Scholar
Breast Tissue Stiffness in Compression is Correlated to Histological Diagnosis
Parris S. Wellman, R. Howe, K. Kern
1999203 citations
Semantic Scholar
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
C. Barrios, Mei-Ching Liu, Soo-Chin Lee, L. Vanlemmens +11 more
2010Breast Cancer Research and Treatment197 citations Open access
Semantic Scholar
Metabolic imaging of human extremity musculoskeletal tumors by PET.
K. Kern, Arturo Brunetti, J. Norton, Alfred E. Chang +5 more
1988Journal of Nuclear Medicine193 citations
Semantic Scholar
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.
J. Crown, V. Diéras, E. Starosławska, D. Yardley +18 more
2013Journal of Clinical Oncology139 citations Open access
Semantic Scholar
Malpractice litigation involving laparoscopic cholecystectomy. Cost, cause, and consequences.
K. Kern
1997Archives of Surgery127 citations
Semantic Scholar
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
C. Papayannidis, D. DeAngelo, W. Stock, Bo Huang +14 more
2015Blood Cancer Journal122 citations Open access
Semantic Scholar
Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
N. Robert, M. Saleh, D. Paul, D. Generali +12 more
2011Clinical Breast Cancer119 citations Open access
Semantic Scholar
Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
K. Kern
2002Journal of the American College of Surgeons109 citations
Semantic Scholar
Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial.
Robert H. Bower, M. Muggia-Sullam, S. Vallgren, J. Hurst +3 more
1986Annals of Surgery97 citations Open access
Semantic Scholar
A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer
Z. Wainberg, M. Alsina, H. Soares, Irene Braña +11 more
2017Targeted oncology94 citations Open access
Semantic Scholar
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
G. Curigliano, X. Pivot, J. Cortes, A. Elias +7 more
2013Breast88 citations
Semantic Scholar
Phase III trial of sunitinib (SU) in combination with capecitabine (C) versus C in previously treated advanced breast cancer (ABC).
J. Crown, V. Diéras, E. Starosławska, D. Yardley +6 more
2010Journal of Clinical Oncology75 citations
Semantic Scholar
Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose.
K. Kern, J. Norton
1987Surgery68 citations
Semantic Scholar
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor
V. Villalobos, Francis T. Hall, A. Jimeno, L. Gore +8 more
2018Annals of Surgical Oncology60 citations
Semantic Scholar
Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid.
K. Kern
2001Journal of the American College of Surgeons56 citations
Semantic Scholar
Sunitinib (SU) in combination with docetaxel (D) versus D alone for the first-line treatment of advanced breast cancer (ABC).
J. Bergh, R. Greil, Nataliya L. Voytko, A. Makhson +6 more
2010Journal of Clinical Oncology52 citations
Semantic Scholar
An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
M. Kozloff, E. Chuang, A. Starr, P. Gowland +6 more
2009Annals of Oncology52 citations Open access
Semantic Scholar
Comparative analysis of complications from I-131 radioablation for well-differentiated thyroid cancer.
G. DiRusso, K. Kern
1994Surgery48 citations
Semantic Scholar
Medicolegal analysis of bile duct injury during open cholecystectomy and abdominal surgery.
K. Kern
1994American Journal of Surgery46 citations
Semantic Scholar
Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique.
K. Kern
2001Journal of the American College of Surgeons41 citations
Semantic Scholar
Medical malpractice involving colon and rectal disease: A 20-year review of United States civil court litigation
K. Kern
1993Diseases of the Colon & Rectum41 citations
Semantic Scholar
The effect of a new branched chain--enriched amino acid solution on postoperative catabolism.
K. Kern, R. Bower, S. Atamian, L. Matarese +2 more
1982Surgery38 citations
Semantic Scholar
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer
G. Curigliano, G. Shapiro, R. Kristeleit, A. A. Abdul Razak +15 more
2022British Journal of Cancer35 citations Open access
Semantic Scholar
Use of a branched chain amino acid enriched solution in patients under metabolic stress.
Robert H. Bower, K. Kern, J. E. Fischer
1985American Journal of Surgery32 citations
Semantic Scholar
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study
T. Bachelot, J. García-Sáenz, S. Verma, M. Gutiérrez +11 more
2014BMC Cancer24 citations Open access
Semantic Scholar
Phase II open-label study of sunitinib in patients with advanced breast cancer
D. Yardley, E. Dees, Stephen D. Myers, Sherry Li +6 more
2012Breast Cancer Research and Treatment23 citations
Semantic Scholar
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.
J. Bergh, G. Mariani, F. Cardoso, A. Liljegren +7 more
2012Breast22 citations Open access
Semantic Scholar
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
K. Autio, C. Higano, L. Nordquist, L. Appleman +20 more
2023Journal for ImmunoTherapy of Cancer20 citations Open access
Semantic Scholar
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.
F. Cardoso, J. Canon, D. Amadori, D. Aldrighetti +7 more
2012Breast19 citations Open access
Semantic Scholar
Phase III Randomized Trial of Sunitinib (SU) vs. Capecitabine (C) in Patients (Pts) with Previously Treated HER2-Negative Advanced Breast Cancer (ABC).
C. Barrios, M. Liu, Sj Lee, L. Vanlemmens +9 more
200917 citations
Semantic Scholar
Gastric cancer: A neoplastic enigma
K. Kern
1989Journal of surgical oncology. Supplement17 citations
Semantic Scholar
An overview of 711 general surgery liability cases. The anatomy of surgical malpractice claims.
K. Kern
1995Bulletin of the American College of Surgeons16 citations
Semantic Scholar
Erythrocyte Transport Function in Cystic Fibrosis
S. Feig, G. B. Segel, K. Kern, A. Osher +1 more
1974Pediatric Research16 citations
Semantic Scholar
When medical error becomes medical malpractice: the victims and the circumstances.
T. Tracy, Linda S Crawford, T. Krizek, K. Kern
2003Archives of Surgery15 citations
Semantic Scholar
Palbociclib plus cetuximab versus placebo plus cetuximab in platinum-resistant, cetuximab-naive, HPV-unrelated head and neck cancer: A double-blind randomized phase II trial (PALATINUS).
D. Adkins, Jin-Ching Lin, A. Sacco, J. Ley +9 more
2019Journal of Clinical Oncology14 citations
Semantic Scholar
First Clinical Report
Parris S. Wellman, Edward P. Dalton, D. Krag, K. Kern +1 more
201514 citations
Semantic Scholar
Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009).
A. Forero-Torres, Heather S. Han, E. Dees, R. Wesolowski +10 more
201813 citations
Semantic Scholar
Trial Design and Efficacy Thresholds for Granting Breakthrough Therapy Designation in Oncology.
K. Kern
2016Journal of Oncology Practice12 citations Open access
Semantic Scholar
Preventing the Delayed Diagnosis of Breast Cancer through Medical Litigation Analysis
K. Kern
199412 citations
Semantic Scholar
The use of high-resolution ultrasound to locate parathyroid tumors during reoperations for primary hyperparathyroidism
K. Kern, T. Shawker, J. Doppman, Donald L. Miller +4 more
1987World Journal of Surgery11 citations
Semantic Scholar
Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib
K. Keyvanjah, S. Deprimo, C. Harmon, Xin Huang +2 more
2012Journal of Translational Medicine10 citations Open access
Semantic Scholar
Abstract P6-12-02: A Randomized Phase II Study of Sunitinib vs. Standard of Care for Patients with Previously Treated Advanced Triple-Negative Breast Cancer
G. Curigliano, X. Pivot, J. Cortés, A. Elias +6 more
201010 citations
Semantic Scholar
Minimally invasive operation for breast cancer.
S. Singletary, K. Dowlatshahi, W. Dooley, S. Hollenbeck +5 more
2004Current problems in surgery9 citations
Semantic Scholar
588 A First-in-patient Phase I Study of the Novel Gamma Secretase Inhibitor PF-03084014 in Patients with Advanced Solid Tumor Malignancies
W. Messersmith, P. LoRusso, J. Cleary, A. Dasari +6 more
20128 citations
Semantic Scholar
Activity and safety of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: initial results from a phase II study.
T. Bachelot, A. Lluch, M. Gutiérrez, Mm Martín +7 more
20098 citations
Semantic Scholar
Historical Trends in Breast Cancer Litigation: A Clinician’s Perspective
K. Kern
19948 citations
Semantic Scholar
Phase I dose-finding study of the gamma secretase inhibitor PF-03084014 (PF-4014) in combination with docetaxel in patients (pts) with advanced triple-negative breast cancer (TNBC).
G. Curigliano, P. Aftimos, E. Dees, P. LoRusso +8 more
20157 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Xin Huang×9
Invite
Xin Huang — researcher profile on SciRah
R. Cesari×8
Invite
R. Cesari — researcher profile on SciRah
Bo Huang×5
Invite
Bo Huang — researcher profile on SciRah
X. Pivot×5
Invite
X. Pivot — researcher profile on SciRah

×4

Invite

C. Giorgetti — researcher profile on SciRah

Invite

T. Bachelot — researcher profile on SciRah

Invite

V. Tassell — researcher profile on SciRah

G. Curigliano×4

Invite

G. Curigliano — researcher profile on SciRah

Invite

R. Greil — researcher profile on SciRah

W. Messersmith×3

Invite

W. Messersmith — researcher profile on SciRah

Invite

G. Shapiro — researcher profile on SciRah

Invite

M. N. Shaik — researcher profile on SciRah